NCT07641322

Brief Summary

The effect of desensitizing agents will be studied on dentin hypersensitivity in orthodontic patients.it is a randomized controlled trial. three experimental groups and one placebo group.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jul 2026Dec 2026

First Submitted

Initial submission to the registry

June 7, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 15, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

3 months

First QC Date

June 7, 2026

Last Update Submit

June 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • REDUCTION IN DENTIN HYPERSENSITIVITY

    Change in dentin hypersensitivity scores from baseline to 8 weeks using the Visual Analog Scale (VAS) and Schiff Cold Air Sensitivity Scale.

    8 WEEKS

Study Arms (4)

TEST TOOTHPASTE GROUP 1

EXPERIMENTAL

Participants in this arm will use the test toothpaste twice daily for 8 weeks.

Other: TOOTH PASTE(NHA)

TEST TOOTH PASTE GROUP 2

ACTIVE COMPARATOR

Participants in this arm will use the test toothpaste twice daily for 8 weeks.

Other: TOOTH PASTE (NOVAMIN)

TEST TOOTH PASTE GROUP 3

ACTIVE COMPARATOR

Participants in this arm will use the test toothpaste twice daily for 8 weeks.

Other: TOOTH PASTE (PROARGIN)

TEST TOOTH PASTE GROUP 4

PLACEBO COMPARATOR

Participants in this arm will use the test toothpaste twice daily for 8 weeks.

Other: TOOTH PASTE ( NON DESENSITIZING)

Interventions

TOOTH PASTES CONTAINING NHA.

TEST TOOTHPASTE GROUP 1

TOOTH PASTE CONTAINING NOVAMIN

TEST TOOTH PASTE GROUP 2

TOOTH PASTE CONTAINING PROARGIN.

TEST TOOTH PASTE GROUP 3

TOOTH PASTE A NON-DESENSITIZING CONTROL

TEST TOOTH PASTE GROUP 4

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Orthodontic patients aged 18-40 years.
  • Presence of mild to moderate dentin hypersensitivity (VAS ≥ 4).
  • Willingness to comply with a 12-week follow-up period.
  • No active periodontal disease or untreated caries.
  • Not pregnant or breastfeeding.
  • No history of allergy to desensitizing agents

You may not qualify if:

  • o Patients with systemic conditions affecting oral health (e.g., diabetes, immunocompromised).
  • Patients using medications that affect tooth sensitivity (e.g., anti-inflammatory drugs).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

NovaMin

Study Officials

  • Dr. Zubair Hassan Awaisi, FCPS

    PRINCIPAL NID MULTAN

    STUDY CHAIR

Central Study Contacts

FATIMA KHALID, BDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Fatima Khalid

Study Record Dates

First Submitted

June 7, 2026

First Posted

June 11, 2026

Study Start

July 15, 2026

Primary Completion (Estimated)

October 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

June 11, 2026

Record last verified: 2026-06